1 INVENTIONS - onlineservices.ipophil.gov.ph · factor Ba, factor Bb, C2, C2a, C3a, C5, C5a, C5b,...

Intellectual Property Center, 28 Upper McKinley Rd. McKinley Hill Town Center, Fort Bonifacio, Taguig City 1634 Philippines

Tel. No. 238-6300 Website: http://www.ipophil.gov.ph e-mail: [email protected] Volume 22 Number 92

Date Released: August 30, 2019

Invention Granted Under R.A. 8293 (PCT)

1 INVENTIONS

[19] INTELLECTUAL PROPERTY PHILIPPINES

[12] INVENTION GRANT

[21] Registration Number: 1/2010/502819 Document Code: B1

[45] Issue Date: 17 May 2019

[22] Date Filed: 14 December 2010

[54] Title: COMPOSITION WITH FAT GRADIENT

[71] Proprietors(s): N.V. NUTRICIA [NL]

[72] Inventor(s): VAN BAALEN, Antoine[NL]: VERDURMEN, Rudolph Eduardos Maria[NL]: VAISMAN, Nachum[IL]: BOEHM, Gunther[DE]

[73] Assignee(s): N.V. NUTRICIA [NL]

[74] Attorney / Agent: HECHANOVA AND CO., INC.

[30] Priority Data: 08158336.1 16/06/2008 EP; 08163478.4 02/09/2008 EP and 61/093,548 02/09/2008 US

[51] International Class 8: A23L 1/29; A23L 1/30

[57] Abstract: The present invention concerns infant formula having a fat gradient which can be established by a sufficient amount of fat droplets with a diameter of 5 - 25 µm based on total weight of fat.

Representative Drawing(s): NONE

[56] Reference(s) Cited and/or Considered:

Document description

WO 2005/051091 A (ENZYMOTEC lTD [Il ]; SHULMAN AVIDOR [I l]; BEN DROR GAl [Il]; PEllED DOR) 9 June 2005

WO 2006/094995 A (NESTEC SA [CHJ; ERDMANN PETER [CHJ; PFALLER WERNER [CHJ;FANKHAUSER PE)

No. of Claims: 26







[45] Issue Date: 7 June 2019

[22] Date Filed: 23 September 2011

[54] Title: USE OF SYNTHETIC AND BIOLOGICAL FUNGICIDES IN COMBINATION FOR CONTROLLING HARMFUL FUNGI

[71] Proprietors(s): BAYER CROPSCIENCE LP [US]

[72] Inventor(s): SCHERER, MARIA[DE]: KLAPPACH, Kristin[DE]: HADEN, Egon[DE]

[73] Assignee(s): BAYER CROPSCIENCE LP [US]

[74] Attorney / Agent: ORTEGA DEL CASTILLO BACORRO CALMA & CARBONELL

[30] Priority Data: 09156360.1 26/03/2009 EP and 09169871.2 09/09/2009 EP

[51] International Class 8: A01N 25/00; A01N 35/04; A01N 37/50; A01N 43/32; A01N 43/36; A01N 43/40; A01N 43/54; A01N 43/653; A01N 43/90; A01N 47/14; A01N 47/24; A01N 63/00; A01P 3/00

[57] Abstract:

The present invention relates to the combined use of synthetic fungicides and biological control agents for controlling harmful fungi. To be more precise, the invention relates to a method for controlling harmful fungi, which comprises at least two treatment blocks, where in at least one treatment block the plants are treated with at least one synthetic fungicide and in at least one treatment block the plants are treated with at least one biological control agent, with the proviso that the last treatment block comprises subjecting the plants to at least one treatment with at least one biological control agent.




RAZIQ F, and fox R.T.V. “The integrated control of Armillaria melea 1. Glasshouse experiments”, Biological Agriculture & Horticulture, Vol. 23, 2006, pages 225-234

RAZIQ F, and fox R.T.V. “The integrated control of Armillaria melea 1. Glasshouse experiments”, Biological Agriculture & Horticulture, Vol. 23, 2006, pages 235-249

WO 94/10845 A2 (Ciba Geigy AG; Becker J. Ole, et al) 26 May 1994

Konstantinidou-Doltsinis S., et al, :Efficacy of Milsana ®, a formulated Plant Extract from Reynoutria sachalinensis, againsts Powdery Mildrew of Tomato (Leveillula taurica)”; Biocontrol, Kluwer Academic Publishers; Vol. 51, No. 3, 31 May 2006.

AGRAQUEST INC. “Rhapsody”, 2008

AGRAQUEST INC. “Serenade-Sonata”, 2008




No. of Claims: 31








[22] Date Filed: 17 June 2013

[54] Title: USE OF COMPLEMENT PATHWAY INHIBITORS TO TREAT OCULAR DISEASES

[71] Proprietors(s): GENENTECH, INC. [US]

[72] Inventor(s): FUNG, Sek, Chung[US]: YAO, Zhengbin[US]

[73] Assignee(s): GENENTECH, INC. [US]

[74] Attorney / Agent: HECHANOVA AND CO. INC.

[30] Priority Data: 60/733,763 04/11/2005 US

[51] International Class 8: A61K 38/00; C07K 17/00

[57] Abstract:

The present invention relates to the treatment of ocular diseases and conditions by administering a complement pathway inhibitor, particularly an alternative pathway inhibitor. Ocular diseases include age-related macular degeneration, diabetic retinopathy, and ocular angiogenesis. One embodiment comprises the administration of an anti-Factor D antibody in the form of a whole antibody, a Fab fragment or a single domain antibody. Other complement component inhibitors that may be useful in the present method include Factor H or inhibitors that block the action of properdin, factor B, factor Ba, factor Bb, C2, C2a, C3a, C5, C5a, C5b, C6, C7, C8, C9, or C5b-9.




BORA ET AL. ROLE OF COMPLEMENT AND COMPLEMENT MEMBRANE ATTACK COMPLEX IN LASER INDUCED CHOROIDAL NEOVASCULARIZATION. J. OF IMMUNOL. 1 JANUARY 2005 VOL. 174 PP. 491 TO 497

US 6 956 107 B2 (FUNG ET AL.) 18 OCTOBER 2005

WO2002/30985 A2 (FUNG ET AL.) 18 APRIL 2002

US2005/0222027 A1 (CHIANG ET AL.) 10 JUNE 2005

US 6 333 034 B1 (GUPTA-BANSAL ET AL.) 25 DECEMBER 2001

WO 99/42133 A1 (TANOX INC.) 26 AUGUST 1999

WO 01/84149 A2 ( UNIV IOWA RES FOUND ET AL.) 08 NOVEMBER 2001

No. of Claims: 15








[22] Date Filed: 14 March 2014

[54] Title: COMPOSITION AND METHOD FOR TEMPORARILY FIXING MEMBER USING SAME

[71] Proprietors(s): DENKA COMPANY LIMITED [JP]

[72] Inventor(s): KURIMURA,Hiroyuki[JP]: TANAKA,Kenji[JP]

[73] Assignee(s): DENKA COMPANY LIMITED [JP]

[74] Attorney / Agent: ROMULO MABANTA BUENAVENTURA SAYOC AND DELOS ANGELES

[30] Priority Data: 2011-201198 14/09/2011 JP

[51] International Class 8: C08F 2/44; C08F 2/50; C08F 220/18; C08F 220/20; C08F 290/06; C08K 9/10; C08L 33/06; C09J 11/06; C09J 11/08; C09J 125/06; C09J 133/00; C09J 133/10; C09J 133/12; C09J 155/00; C09J 4/02; C09J 5/00

[57] Abstract:

The purpose of the present invention is to provide an adhesive composition for temporary fixation which has high adhesive strength, offers excellent peeling performance when in water, can be applied even to members having optically opaque sites, and offers both excellent environmental performance and excellent workability in that a member after peeling will have no adhesive deposits. The present invention is a composition for temporary fixation whereby a cured article of a composition used to adhere members together is immersed in water, immersing the adhered members both in water and detaching same. The composition is a two-agent composition in which a composition containing a multi-functional (meth)acrylate (A), a monofunctional (meth)acrylate (B), an organic peroxide (C), a degradation accelerator (D), a photopolymerization initiator (E), and a particulate substance (G) is divided into two agents, the first agent containing at least (C) and the second agent containing at least (D).




US 2010/0012263 A1 OSHIMA, Kazuhiro et al. 21 January 2010

US 2013/0233479 A1 KURIMURA, Hiroyuki et al 12 September 2012

No. of Claims: 27








[22] Date Filed: 14 April 2014

[54] Title: NUTRITIONAL PHYTONUTRIENT COMPOSITIONS

[71] Proprietors(s): MJN U.S. HOLDINGS LLC [US]

[72] Inventor(s): JOUNI, Zeina[US]: CEVALLOS, Bolivar[US]: HORIA, Eva[ID]: HARTHOORN, Lucien[NL]: KINEMAN, Brian[US]: GAYGADZHIEV, Zafir[BG]: TALLEY, Kelli[US]

[73] Assignee(s): MJN U.S. HOLDINGS LLC [US]

[74] Attorney / Agent: CASTILLO LAMAN TAN PANTALEON & SAN JOSE LAW OFFICES

[30] Priority Data: 13/273,635 14/10/2011 US

[51] International Class 8: A23L 1/00; A23L 1/29; A23L 1/30; A23L 1/305

[57] Abstract:

The present disclosure relates to milk-based nutritional compositions for pediatric subjects and to corresponding methods of using the nutritional compositions to promote health and development. The nutritional compositions comprise docosahexaenoic acid, choline and phytonutrients, such as apple extract, grape seed extract, or mixtures thereof. The nutritional compositions are believed to be useful in promoting visual health, gastrointestinal health, immune function and cognitive development and function in infants and children, and the compositions may be administered via a staged nutritional feeding regimen. The disclosure further relates to nutritional compositions that maintain desirable organoleptic properties after addition of phytonutrients to a milk-based matrix and still further relates to methods for producing the same.




D1: US 2007/116802 A1 (GERMANO, C.) 24 May 2007

D2: US 2006/210697 A1 (MOWER, T.) 21 September 2006*

PRIOR, Ronald L. “Occurence and biological significance of proanthocyanidins in the American diet.” Phytochemistry 66, n. 18 (May 2005): 2265 - 2280

No. of Claims: 25








[22] Date Filed: 2 May 2014

[54] Title: VACCINES DIRECTED AGAINST HUMAN ENTEROVIRUSES

[71] Proprietors(s): SENTINEXT THERAPEUTICS SDN BHD [MY]

[72] Inventor(s): CARDOSA, Mary, Jane[MY]: JAMILUDDIN, Mohamad, Fakruddin[MY]: HAMID, Sharifah, Binti[MY]

[73] Assignee(s): SENTINEXT THERAPEUTICS SDN BHD [MY]

[74] Attorney / Agent: HECHANOVA & CO., INC.

[30] Priority Data: PI2011005318 03/11/2011 MY

[51] International Class 8: A61K 39/125; A61K 39/13; A61K 39/135

[57] Abstract:

The instant invention provides materials and methods for producing immunologically active antigens derived from members of the Picornaviridae virus family. The picornavirus antigens of the invention may be in a form for use as a vaccine administered to a subject in a therapeutic treatment or for the prevention of a picornavirus infection. The picornavirus antigens of the invention may be in the form of an immunogenic composition for use in vaccines which are administered for the prevention of an Enterovirus infection. The instant invention further encompasses immunogenic compositions comprising Human enterovirus A, Human enterovirus B, Human enterovirus C, Human enterovirus D antigens and their use in vaccines for the prevention of an Enterovirus infection.

Representative Drawing(s):



CHUNG,C-Y et al.: Ënterovirus 71 virus-like particle vaccine: Improved production conditions for enhanced yield." Vaccine. 2010 Oct 8




CHUNG, Y-C et al.: "Immunization with virus- like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge."Vaccine. 2008 mar 28

No. of Claims: 12







[45] Issue Date: 9 July 2019

[22] Date Filed: 25 July 2014

[54] Title: PROCESS FOR ENHANCING ELECTROSTATIC SEPARATION IN THE BENEFICIATION OF ORES

[71] Proprietors(s): CYTEC TECHNOLOGY CORP. [US]

[72] Inventor(s): RAVISHANKAR, Sathanjheri[US]: KOLLA, Harsha S.[US]: WANG, Bing[US]

[73] Assignee(s): CYTEC TECHNOLOGY CORP. [US]

[74] Attorney / Agent: SYCIP, SALAZAR, HERNANDEZ AND GATMAITAN

[30] Priority Data: 61/110,282 31/10/2008 US and 61/171,305 21/04/2009 US

[51] International Class 8: B03C 7/00

[57] Abstract: An electrostatic modification reagent as described herein. The electrostatic modification reagent may be used in an electric separation process for separating components from a mineral ore or sand.




US 2007/0007179 A1 (Ravishankar, Sathanjheri A.) 11 January 2007 (11.01.2007)

US 6,168,029 B1 (Henderson, Raymond Leslie et al.) 02 January 2001 (02.01.2001)

US 4,834,898 (Hwang, Jiann-Yang) 30 May 1989 (30.05.1989)

US 4,743,364 (KYRAZIS, Demos T.) 10 May 1988 (10.05.1988)

US 5,106,489 (SCHMIDT, Roland et al.) 21 April 1992 (12.04.1992)

US 4,131,539 (OJIRI, Kozo et al.) 26 December 1978 (26.12.1978)

No. of Claims: 30







[45] Issue Date: 9 July 2019


[54] Title: USE OF A VISCOSITY IMPROVER

[71] Proprietors(s): SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. [NL]

[72] Inventor(s): BALTHASAR, Felix Johannes[DE]: EGGENSTEIN, Matthias[DE]

[73] Assignee(s): SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. [NL]

[74] Attorney / Agent: ORTEGA, BACORRO, ODULIO, CALMA & CARBONELL

[30] Priority Data: 12159796.7 16/03/2012 EP

[51] International Class 8: C10L 1/10; C10L 1/14; C10L 1/16; C10L 1/196; C10L 10/00

[57] Abstract:

Use of a viscosity-improving additive, in a diesel fuel formulation, for the purpose of increasing the compressibility of the formulation. The viscosity-improving additive may be selected from (i) olefin-based polymers (in particular styrene-based polymers); (ii) base oils naphthenic, paraffinic or synthetic; (iii) polymethacrylates; and (iv) mixtures thereof. It may be used to increase the isothermal compressibility of the diesel fuel formulation at typical fuel injection pressures and temperatures, and in turn to improve the power- related performance of a compression ignition engine running on the fuel formulation.




MAGIN LAPUERTA ET AL: "Bulk modulus of Compressibility of Diesel/Biodiesel/HVO Blends", ENERGY & FUELS, Vol. 26, no. 2, 16 February 2012, pages 1336-1343

BE 371 525A (Benzol-Verband GmbH), 31 July 1930

US 2009/241882A1 (Brunner Andreas Hugo [DE] et al.), 1 October 2009

WO 2005/054411A1 (Shell Int. Research [NL], et al.), 16 June 2005

No. of Claims: 16








[22] Date Filed: 19 November 2014

[54] Title: WATER CLARIFICATION COMPOSITION AND PROCESS

[71] Proprietors(s): UNILEVER N.V. [NL]

[72] Inventor(s):

BARNE, Sameer Keshav[IN]: PATHAK, Gaurav[IN]: RAJAGOPAL, Ramasubramaniam[IN]: RAJENDIRAN, Ganesan[IN]: SANKAR, Rachana[IN]: SHAH, Bijal Dharmvirbhai[IN]: SHRESTH, Rudra Saurabh[IN]: SINHA, Archana[IN]

[73] Assignee(s): UNILEVER N.V. [NL]

[74] Attorney / Agent: OSCAR M. MANAHAN, ESQ.

[30] Priority Data: 12173601.1 26/06/2012 EP

[51] International Class 8: C02F 1/52; C02F 1/56

[57] Abstract:

The present invention is in the field of water purification compositions and processes. In particular the invention relates to the clarification of laundry wash and/or rinse liquor for water saving by re-use. A fast water purification and clarification process for the treatment of household water, especially laundry wash and more typically laundry rinse water remains to be desired. It is therefore an object of the present invention to provide water saving in household process, especially laundry processes, especially hand wash; especially in a short time. We have found that a composition comprising flocculant, coagulant, filler and cationic surfactant provides effective water clarification and purification.




FR 2,870,229 A1 (ACIDEKA SA SA [ES]) 18 November 2005

No. of Claims: 12









[54] Title: ORAL CARE COMPOSITIONS

[71] Proprietors(s): UNILEVER N.V. [NL]

[72] Inventor(s): ASHCROFT, Alexander, Thomas[GB]: BRENNAN, Lee, James[GB]: WILSON, William, John[GB]

[73] Assignee(s): UNILEVER N.V. [NL]

[74] Attorney / Agent: OSCAR M. MANAHAN, ESQ.

[30] Priority Data: 12194410.2 27/11/2012 EP

[51] International Class 8: A61K 8/19; A61K 8/73; A61K 8/97; A61Q 11/00

[57] Abstract:

The invention provides an oral care composition suitable for cleaning the surfaces of the oral cavity, the composition comprising: an aqueous continuous phase including at least 1% by weight (based on the total weight of the composition) of one or more polyhydric alcohols; from 1 to 70% by weight (based on the total weight of the composition) of particulate calcium carbonate abrasive which is dispersed in the aqueous continuous phase, characterised in that the aqueous continuous phase is structured with a matrix of activated citrus fibre particles.




US 2007/0166242 A1 (KROSS) 19 JULY 2007

US 2004/0086626 A1 (LUNDBERG ET AL) 6 MAY 2004

No. of Claims: 10









[54] Title: STABLE METAL ION CONTAINING COMPOSITIONS

[71] Proprietors(s): COLGATE-PALMOLIVE COMPANY [US]

[72] Inventor(s): XU, Yun[CN]: HUANG, Xiaoyi[CN]: XIE, Yuanhui[CN]: QIN, Xiongfei[CN]

[73] Assignee(s): COLGATE-PALMOLIVE COMPANY [US]

[74] Attorney / Agent: MIRANDAH ASIA (PHILIPPINES) INC.

[30] Priority Data: NONE

[51] International Class 8: A61K 8/27; A61Q 11/00

[57] Abstract:

Disclosed herein are oral care compositions comprising: a) one or more pyrophosphate compounds, wherein the total concentration of pyrophosphate compounds in the composition is 0.5 wt% to 1.5 wt%, based on the weight of the oral care composition; b) one or more thickening gums, wherein the total concentration of thickening gums in the composition is 1.25 wt% to 1.6 wt%, based on the weight of the oral care composition; and c) a metal ion source.




US 2012/0064017 A1; PORTER et al.; 15 March 2012 (15.03.2012)

No. of Claims: 25









[54] Title: STABILIZED HUMAN IMMUNODEFICIENCY VIRUS (HIV) ENVELOPE (ENV) TRIMER VACCINES AND METHODS OF USING SAME

[71] Proprietors(s): BETH ISRAEL DEACONESS MEDICAL CENTER, INC [US]

[72] Inventor(s): BAROUCH, Dan, H[US]: NKOLOLA, Joseph[US]

[73] Assignee(s): BETH ISRAEL DEACONESS MEDICAL CENTER, INC [US]

[74] Attorney / Agent: SAPALO VELEZ BUNDANG & BULILAN LAW OFFICES

[30] Priority Data: 61/749,737 07/01/2013 US

[51] International Class 8: A61K 38/00

[57] Abstract:

The invention features stabilized human immunodeficiency virus (HIV) envelope (Env) trimers. The invention also features vaccines, nucleic acids, and vectors to deliver and/or facilitate production of the stabilized HIV Env trimers. In addition, the invention features methods of making and using the stabilized HIV Env trimers of the invention as vaccines.




WO 20101059732 A1 (BETH ISRAEL HOSPITAL) 27 May 2010

US 2012/0045472 A1 (HARRISON et al) 23 February 2012

No. of Claims: 32









[54] Title: EXCITATION AND USE OF GUIDED SURFACE WAVE MODES ON LOSSY MEDIA

[71] Proprietors(s): CPG TECHNOLOGIES, LLC [US]

[72] Inventor(s): CORUM, James, F.[US]: CORUM, Kenneth, L.[US]

[73] Assignee(s): CPG TECHNOLOGIES, LLC [US]


[30] Priority Data: 13/789,525 07/03/2013 US and 13/789,538 07/03/2013 US

[51] International Class 8: H01Q 1/04; H01Q 1/36

[57] Abstract: Disclosed are various embodiments for transmitting and/or receiving energy conveyed in the form of a guided surface-waveguide mode along the surface of a lossy conducting medium by exciting a polyphase waveguide probe.




US4751515 (A) CORUM 14 June 1988

US3123767 (A) Ghose 03 March 1964

No. of Claims: 63









[54] Title: TETRAHYDROPYRROLOTHIAZINE COMPOUNDS

[71] Proprietors(s): ELI LILLY AND COMPANY [US]

[72] Inventor(s): GREEN, Steven James[US]: MERGOTT, Dustin James[US]: WATSON, Brian Morgan[US]: WINNEROSKI JR., Leonard Larry[US]

[73] Assignee(s): ELI LILLY AND COMPANY [US]

[74] Attorney / Agent: AGCAOILI & ASSOCIATES

[30] Priority Data: 61/776,819 12/03/2013 US

[51] International Class 8: A61K 31/547; A61P 25/28; C07D 513/04

[57] Abstract:

The present invention provides a compound of Formula (I):

wherein R is H or F; and A is

(A), (B), (C) or (D); or a pharmaceutically acceptable salt thereof.




WO 2012/098213 A1 (EISAI R&D MAN CO LTD ET AL.) 26 JULY 2012

US 2009 209 755 A1 (SUZUKI YUICHI ET AL.) 20 AUGUST 2009

No. of Claims: 12









[54] Title: NUTRITIONAL COMPOSITIONS CONTAINING A PEPTIDE COMPONENT WITH ANTI-INFLAMMATORY PROPERTIES AND USES THEREOF

[71] Proprietors(s): MJN U.S. HOLDINGS LLC [US]

[72] Inventor(s): HONDMANN, Dirk[US]: VAN TOL, Eric A.F[NL]: GROSS, Gabriele[NL]: SCHOEMAKER, Marieke H[NL]: LAMBERS, Teartse Tim[NL]

[73] Assignee(s): MJN U.S. HOLDINGS LLC [US]


[30] Priority Data: 13/833,094 15/03/2013 US

[51] International Class 8: A23L 1/305; A61K 38/01; A61K 38/07; A61K 38/08

[57] Abstract:

The present disclosure relates to nutritional compositions comprising a protein equivalent source, wherein 20% to 80% of the protein equivalent source includes a peptide component comprising SEQ ID NO 4, SEQ ID NO 13, SEQ ID NO 17, SEQ ID NO 21, SEQ ID NO 24, SEQ ID NO 30, SEQ ID NO 31, SEQ ID NO 32, SEQ ID NO 51, SEQ ID NO 57, SEQ ID NO 60, and SEQ ID NO 63, and 20% to 80% of the rotein equivalent source comprises an intact protein, a partially hydrolyzed protein, or combinations thereof. The disclosure further relates to methods of reducing the inflammatory response and/or production of proinflammatory cytokines, i.e. Interleukin-17, by providing said nutritional compositions to a target subject.




P Requena et al: “Bovine glycomacropeptide ameliorates experimental rat ileitis by mechanisms involving downregulation of interleukin 17,” British Journal of Pharmacology, vol. 154, no. 4, 29 June 2008, pages 825-832

WO 2005/081628 A1 (CHAY 13 MEDICAL RESEARCH GROUP N.V.) 13 SEPTEMBER 2005

WO 2011/069042 A2 (MEAD JOHNSON NUTRITION COMPANY) 09 JUNE 2011

No. of Claims: 20









[54] Title: SUGAR CHAIN-POLYPEPTIDE COMPLEX

[71] Proprietors(s): GLYTECH, INC. [JP]

[72] Inventor(s): SAIJO, Hayato[JP]: OCHIAI, Hirofumi[JP]: TAZURU, Keisuke;[JP]: SHIMODA, Taiji[JP]

[73] Assignee(s): GLYTECH, INC. [JP]

[74] Attorney / Agent: CASTILLO LAMAN TAN PANTALEON & SAN JOSE

[30] Priority Data: 2013-075493 30/03/2013 JP

[51] International Class 8: A61K 38/14; A61K 47/42; A61K 47/61; A61L 15/32; A61L 26/00; A61L 33/12

[57] Abstract:

The object of the present invention is to provide a sugar chain-polypeptide complex that may form a transparent and homogeneous hydrogel in a broad pH. The present invention provides a sugar chain-polypeptide complex, characterized in that said polypeptide is a polypeptide comprising an amino acid sequence consisting of 8-34 amino acid residues in which polar and nonpolar amino acid residues are alternately arranged, and one or more sugar chains are bound to said polypeptide.




WO 2008/113030 A2 (ARCH THERAPEUTICS INC, ET AL.) 18 September 2008.

CARLOS J. BOSQUES ET AL.: “Effects of Glycosylation on Peptide Conformation: A Synergistic Experimental & Computational Study”, JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 18 June 2004, vol. 126, no. 27, pages 8421-8425, XP055287782.

No. of Claims: 22








[22] Date Filed: 22 December 2015

[54] Title: SQUEEZING DEVICE, FUEL PELLET MANUFACTURING FACILITY AND SQUEEZING METHOD

[71] Proprietors(s): NIPPON STEEL AND SUMIKIN ENGINEERING CO., LTD. [JP]

[72] Inventor(s): IKEZAKI Toru[JP]: KOGA Ryuuji[JP]: NISHI Takeshi[JP]: YOSHIDA Masayoshi[JP]: TAKEMARU Hiroshi[JP]

[73] Assignee(s): NIPPON STEEL AND SUMIKIN ENGINEERING CO., LTD. [JP]

[74] Attorney / Agent: ROMULO MABANTA BUENAVENTURA SAYOC AND DELOS ANGELES

[30] Priority Data: 2013-136851 28/06/2013 JP and 2014-039789 28/02/2014 JP

[51] International Class 8: B09B 3/00; B30B 9/20; C10L 5/44

[57] Abstract:

The present invention is provided with: an inscribed roll (3) which is rotatably disposed; a rotatable ring roll (2) in which the inscribed roll (3) is disposed in a space portion formed therein, and which is disposed such that a center distance between a rotation center of the inscribed roll (3) and a rotation center of the ring roll (2) is variable; an inscribed roll rotating unit which rotates the inscribed roll (3); a pressing roll (4) which is disposed outside the ring roll (2) and presses an outer circumferential face of the ring roll (2); an adjustment unit (33A) which relatively moves the inscribed roll (3) and the pressing roll (4) in a direction in which the rolls come close to or are spaced away from each other, thereby adjusting a center distance between the rotation center of the inscribed roll (3) and a rotation center of the pressing roll (4), and a ring roll-rotating unit which rotates the ring roll (2) in which an object to be squeezed which has been fed into the space portion of the ring roll (2) is squeezed between an inner circumferential face of the ring roll (2) and an outer circumferential face of the inscribed roll (3) while being in direct contact with the inner circumferential face of the ring roll (2) and the outer circumferential face of the inscribed roll (3).







US2374047 A Stacom Process Corp. April 17, 1945

FR1513505 A J. Dollat & Cie February 16, 1968

JP48-12565 A Ishikagi Kiko Kabushiki Kaisha February 16, 1973

No. of Claims: 17








[22] Date Filed: 5 February 2016

[54] Title: RECORDING APPARATUS

[71] Proprietors(s): SEIKO EPSON CORPORATION [JP]

[72] Inventor(s): TANAKA, Yoshiyuki[JP]

[73] Assignee(s): SEIKO EPSON CORPORATION [JP]

[74] Attorney / Agent: FEDERIS AND ASSOCIATES LAW OFFICES

[30] Priority Data: 2013-177661 29/08/2013 JP

[51] International Class 8: B41J 2/01; B41J 2/175

[57] Abstract:

There is a problem that a recording apparatus is increased in size if the recording apparatus includes a holding section that holds an ink pack of a large capacity separately from a main device. A recording apparatus includes an opening section 30 which is formed on an outside surface of a housing 25 and through which a sheet cassette 29 is inserted, ink containers 17a and 17b that store ink, cases 18 that are disposed on outside surfaces on both sides adjacent to an outside surface on which the opening section 30 of the housing 25 is formed and holds the ink containers 17a and 17b, and a tube that supplies the ink from ink containers 17a and 17b to the inside of the housing 25, in which sizes of the cases 18 on both sides are different from each other.







US 5369429 A1 / ERICKSON, Paul E. / 29 November 1994

US 2004125182 A1 / AKERMALM Per G. / 01 July 2004

No. of Claims: 9









[54] Title: HERBICIDE COMPOSITION

[71] Proprietors(s): ISHIHARA SANGYO KAISHA, LTD. [JP]

[72] Inventor(s): YAMADA, Ryu[--]: OKAMOTO, Hiroyuki[--]: TERADA, Takashi[--]

[73] Assignee(s): ISHIHARA SANGYO KAISHA, LTD. [JP]

[74] Attorney / Agent: FEDERIS AND ASSOCIATES LAW OFFICES

[30] Priority Data: 2013-220680 23/10/2013 JP

[51] International Class 8: A01N 43/54; A01N 47/36; A01P 13/02

[57] Abstract: To provide a high active herbicidal composition to control undesired plants represented by weeds to be controlled. A herbicidal composition comprising tiafenacil or its salt and flazasulfuron or its salt.




US2011/0224083 A1 (KO, YOUNG KWAN ET. AL.) 15 September 2011

WO 2013/154396 A1 (DONGBU FARM HANNONG CO., LTD) 17 October 2013

No. of Claims: 7









[54] Title: COMMUNICATION CONTROL DEVICE, COMMUNICATION CONTROL METHOD, TERMINAL DEVICE, AND INFORMATION PROCESSING DEVICE

[71] Proprietors(s): SONY CORPORATION [JP]

[72] Inventor(s): TAKANO, Hiroaki[JP]

[73] Assignee(s): SONY CORPORATION [JP]

[74] Attorney / Agent: SYCIP, SALAZAR, HERNANDEZ AND GATMAITAN

[30] Priority Data: 2013-199371 26/09/2013 JP

[51] International Class 8: H04W 8/00; H04W 92/18

[57] Abstract:

To make it possible to moderate the load for a device conducting device-to-device communication (D2D communication). There is provided a communication control device including an acquisition unit configured to acquire radio frame information indicating a radio frame, the radio frame being a unit time of cellular communication, for transmitting a discovery signal enabling another device to discover a device conducting device-to-device communication, and a control unit configured to control transmission of the radio frame information to a terminal device.




US 20130083779 A1 (AHN et al.) 04 April 2013

"D2D Discovery In LTE" , 3GPP TSG-RAN WGI Meeting #73 Rl-132187, Retrieved from: http://www.3gpp.org/DynaReport/ TDocExMtg--R1-73--30043.htm Retrieved date: 16 January 2019 24 May 2013

No. of Claims: 10









[54] Title: SMOKING COMPOSITION COMPRISING FLAVOUR PRECURSOR

[71] Proprietors(s): PHILIP MORRIS PRODUCTS S.A. [CH]

[72] Inventor(s): HUFNAGEL, Jan Carlos[DE]: GLABASNIA, Anneke[DE]: ARAMENDY, Flavie[FR]

[73] Assignee(s): PHILIP MORRIS PRODUCTS S.A. [CH]

[74] Attorney / Agent: SIGUION REYNA MONTECILLO & ONGSIAKO LAW OFFICES

[30] Priority Data: 13194143.7 22/11/2013 EP and 61/907,441 22/11/2013 US

[51] International Class 8: A24B 15/30; A24D 1/00; A24F 47/00

[57] Abstract:

A smoking composition comprises an aerosol-forming substrate and a flavour precursor compound. Upon heating, the precursor compound releases a thiol-containing flavour compound or intermediate that enhances the flavour experience of the aerosol- forming substrate when used in a smoking article. The smoking article may include tobacco and may be configured to heat, but not combust, the tobacco.




US4941486 (DUBE MICHAEL F. et al) 17 July 1990

No. of Claims: 27









[54] Title: CONVEYANCE SYSTEM FOR OBJECT TO BE CONVEYED AND CONVEYANCE METHOD

[71] Proprietors(s): TOYOTA STEEL CENTER CO., LTD. [JP]

[72] Inventor(s): ITO, Nobuaki[JP]: MATSUMOTO, Manabu[JP]

[73] Assignee(s): TOYOTA STEEL CENTER CO., LTD. [JP]

[74] Attorney / Agent: MANUEL C. CASES, JR & ASSOCIATES

[30] Priority Data: NONE

[51] International Class 8: B60P 3/00; B65D 19/44; B65G 67/02

[57] Abstract:

Provided is a conveyance system (1, 101) for an object to be conveyed that makes it possible to easily and quickly convey an object to be conveyed (Q) to a container (3) that is mounted on the chassis (2a) of a trailer (2) and to load the maximum loading amount of the object to conveyed (Q) in the container (3). This conveyance system (1, 101) is provided with a jack device (5) that lifts the chassis (2a) from below and a stage device (6, 102) that is arranged behind the jack device (5). The stage device (6, 102) is provided with: a conveyance body (21, 104) on which the object to be conveyed (Q) is placed and conveyed; a stage (22, 105) on which the conveyance body (21, 104) travels; a mobile body (23) that supports the stage (22, 105) and that is capable of movement in the front-back direction of the chassis (2a); and a jack mechanism (24) that is provided to the mobile body (23) and that lifts the stage (22, 105) from below so that said stage (22, 105) is raised or lowered.




US 5082415 A (HAYASHI) - 21 January 1992

US 3710961 A (BOMSTEIN) - 16 January 1973

US 6318947 B1 (HAHN, et al.) - 20 November 2001




US 4469277 A (HOWES) - 04 September 1984

No. of Claims: 8








[22] Date Filed: 27 May 2016

[54] Title: DENTIFRICE COMPOSITIONS COMPRISING ZINC OXIDE AND ZINC CITRATE

[71] Proprietors(s): COLGATE-PALMOLIVE COMPANY [US]

[72] Inventor(s): PRENCIPE, Michael[US]: XU, Yun[CN]: HUANG, Xiao Yi[CN]: FISHER, Steven[US]: WON, Betty[US]: SCHAEFFER-KORBYLO, Lyndsay[US]

[73] Assignee(s): COLGATE-PALMOLIVE COMPANY [US]

[74] Attorney / Agent: MIRANDAH ASIA (PHILIPPINES) INC.

[30] Priority Data: 201310701692.8 19/12/2013 CN

[51] International Class 8: A61K 8/27; A61P 1/02; A61Q 11/00

[57] Abstract: Described herein are oral care compositions comprising a combination of zinc oxide and zinc citrate, and methods of preparing and using the same.




WO 2012/087288 A2 COLGATE PALMOLIVE CO 28 June 2012

WO 2010/138492 A2 COLGATE PALMOLIVE CO 2 December 2010

No. of Claims: 18









[54] Title: PROCESSES FOR PRODUCING EFFECTS LAYERS

[71] Proprietors(s): SICPA HOLDING SA [CH]

[72] Inventor(s): SCHMID, Mathieu[CH]: DESPLAND, Claude-Alain[CH]: LOGINOV, Evgeny[CH]: AMERASINGHE, Cédric[CH]: DEGOTT, Pierre[CH]

[73] Assignee(s): SICPA HOLDING SA [CH]

[74] Attorney / Agent: SYCIP SALAZAR HERNANDEZ AND GATMAITAN

[30] Priority Data: 13197160.8 13/12/2013 EP

[51] International Class 8: B05D 5/06

[57] Abstract:

The invention relates to the field of the protection of security documents such as for example banknotes and identity documents against counterfeit and illegal reproduction. In particular, the present invention provides processes for producing optical effect layers (OELs) on a substrate and OELs obtained thereof, said process comprising two magnetic orientation steps: a step of exposing a coating composition comprising platelet-shaped magnetic or magnetisable pigment particles to a dynamic magnetic field of a first magnetic-field-generating device so as to bi-axially orient at least a part of the platelet-shaped magnetic or magnetisable pigment particles and a step of exposing the coating composition to a static magnetic field of a second magnetic-field-generating device, thereby mono-axially reorienting at least a part of the platelet-shaped magnetic or magnetisable pigment particles.







WO 2013/117534 A1 NESTEC SA 15 August 2013

WO 2005/016023 UNILEVER PLC 24 February 2005

No. of Claims: 23









[54] Title: SUBSTITUTED BICYCLIC HETEROARYL COMPOUNDS AS RXR AGONISTS

[71] Proprietors(s): CONNEXIOS LIFE SCIENCES PVT. LTD. [IN]

[72] Inventor(s): RANGA, Madhavan Gurram[IN]: RAO, Jagannath Madanahalli Ranganath[IN]: GUDLA, Chandra Sekhar[IN]

[73] Assignee(s): CONNEXIOS LIFE SCIENCES PVT. LTD. [IN]


[30] Priority Data: 161/CHE/2014 14/01/2014 IN

[51] International Class 8: A61K 31/381; A61K 31/428; A61K 31/4436; A61K 31/506; A61P 3/10; C07D 235/16; C07D 277/60; C07D 409/04; C07D 409/06; C07D 409/08; C07D 409/12; C07D 417/04; C07D 417/06; C07D 417/12

[57] Abstract:

The present invention relates to certain substituted bicyclic compounds that are agonists of RXR and which are therefore useful in the treatment of certain disorders that can be prevented or treated by activation of this receptor. In addition the invention relates to the compounds, methods for their preparation, pharmaceutical compositions containing the compounds and the uses of these compounds in the treatment of certain disorders.




WO 2008/030618 A1 (AMGEN INC.) 13 March 2008 (13.03.2008)

No. of Claims: 133









[54] Title: CONNECTION DEVICE FOR CONNECTING TWO FLUID CIRCUITS

[71] Proprietors(s): GAZTRANSPORT ET TECHNIGAZ [FR]

[72] Inventor(s): GELIN, Guillaume[FR]

[73] Assignee(s): GAZTRANSPORT ET TECHNIGAZ [FR]

[74] Attorney / Agent: POBLADOR BAUTISTA AND REYES

[30] Priority Data: 1450821 03/02/2014 FR

[51] International Class 8: F16L 37/107; F16L 37/36

[57] Abstract:

Connection device for connecting two fluid circuits having two connectors (2), each designed to be mounted on one of the circuits (1), wherein each connector comprises: a fluid conduit (4) designed to cooperate with the conduit of the other connector to form a fluid passage between the connectors, a first valve (7) and a second valve (7) located in the conduit and capable of selectively sealing or opening the conduit, wherein the conduit comprises a buffer space (16) defined by an inner wall of the fluid conduit, the first valve and the second valve, a first actuator (8) of the first valve and a second actuator (9) of the second valve. The connection device further comprising a coupling element (13) capable of sealingly coupling the conduits of the connector.




US2005103387 (A1) VOEGE et al. 19 May 2005

US2013146146 (A1) SETHRE 13 June 2013

WO8201929 (A1) KAMPMANN HELMUT 10 June 1982

FR2311989 (A2) UTILISATION RATION GAZ 17 December 1976

No. of Claims: 29








[22] Date Filed: 7 October 2016

[54] Title: CIRCUMCISION AID

[71] Proprietors(s): CIRCUMQ IP (RF) (PTY) LTD. [ZA]

[72] Inventor(s): VAN WYK, Hendrik, Jakobus[ZA]

[73] Assignee(s): CIRCUMQ IP (RF) (PTY) LTD. [ZA]


[30] Priority Data: 2014/2562 09/04/2014 ZA

[51] International Class 8: A61B 17/326

[57] Abstract:

The invention describes a single circumcision aid which limits circumcision scar formation and facilitates a fast healing time period. The circumcision aid includes a tubular section having a glans penis locating portion at a first open end region thereof, an opposite second end region and a body therebetween, the body including a threaded portion being received by a screw means. The circumcision aid also includes a framework providing stability to the aid, a crush means and a locking means.




WO2009/091235 A2 Salleh July 23, 2009

WO2014/094005 A1 Meditech Global June 19, 2014

WO2007/145595 A1 Seow Kin Siang December 21, 2007

WO2002/060329 A1 Circumbent BV August 8, 2002

No. of Claims: 14








[22] Date Filed: 11 October 2016

[54] Title: LOOP FLOW TYPE BUBBLE GENERATION NOZZLE

[71] Proprietors(s): OK ENGINEERING CO., LTD. [JP]

[72] Inventor(s): MATSUNAGA Takeshi[JP]: MATSUNAGA Daisuke[JP]

[73] Assignee(s): OK ENGINEERING CO., LTD. [JP]

[74] Attorney / Agent: VERALAW (DEL ROSARIO RABOCA GONZALES GRASPARIL)

[30] Priority Data: 2014-082085 11/04/2014 JP

[51] International Class 8: B01F 3/04; B01F 5/00; B01F 5/04; B05B 1/02; B05B 7/04

[57] Abstract:

There is provided a loop flow type bubble generation nozzle capable of improving the bubble generation efficiency compared to conventional nozzles without reducing the bubble generation efficiency even when liquid containing impurities is used. A loop flow type bubble generation nozzle 10 includes a tubular bottomed member 1 having a circular cross section and a tubular member 2 which is fitted into the other end side of the bottomed member 1. A substantially cylindrical space surrounded by the bottomed member 1 and the tubular member 2 serves as a loop flow type gas-liquid stirring and mixing chamber 6. The tubular member 2 has, on the center thereof, an inflow hole 7 which is capable of allowing liquid and gas to flow therein, and a first jet hole 8a and a second jet hole 8b which are capable of jetting liquid and gas. The inflow hole 7 is formed in a tapered shape whose diameter continuously expands from the first jet hole 8a toward the loop flow type gas-liquid stirring and mixing chamber 6. A plurality of cut-away parts 7a are formed on an end face of the inflow hole 7, the end face facing the loop flow type gas-liquid stirring and mixing chamber 6.







JP2009-189984 A Yugen Kaisha OK Engineering August 27, 2009

JP2008-62151 A Nishida Tekko Corp. March 21, 2008

JP2008-114098 A Sanyo Facilities Industry Co., Ltd. May 22, 2008

No. of Claims: 7








[22] Date Filed: 28 February 2017

[54] Title: COMPOUNDS THAT INHIBIT MCL-1 PROTEIN

[71] Proprietors(s): AMGEN INC. [US]

[72] Inventor(s):

BROWN, Sean P.[US]: LI, Yunxiao[US]: LIZARZABURU, Mike Elias[US]: LUCAS, Brian S.[US]: PARAS, Nick A.[US]: TAYGERLY, Joshua[US]: VIMOLRATANA, Marc[US]: WANG, Xianghong[US]: YU, Ming[US]: ZANCANELLA, Manuel[US]: ZHU, Liusheng[US]: GONZALEZ BUENROSTRO, Ana[US]: LI, Zhihong[US]

[73] Assignee(s): AMGEN INC. [US]


[30] Priority Data: 62/043,929 29/08/2014 US

[51] International Class 8: A61K 31/554; A61P 35/00; C07D 513/08

[57] Abstract:

Provided herein are myeloid cell leukemia 1 protein (Mcl-1) inhibitors, methods of their preparation, related pharmaceutical compositions, and methods of using the same. For example, provided herein are compounds of Formula I,

and pharmaceutically acceptable salts thereof and pharmaceutical compositions containing the compounds. The compounds and compositions provided herein may be used, for example, in the treatment of diseases or conditions, such as cancer.




WO 2013/149124 Al (UNIV MICHIGAN) 3 October 2013

WO 2008/131000 A2 (ABBOTT LABORATORIES) 30 October 2008

No. of Claims: 215

1 INVENTIONS - onlineservices.ipophil.gov.ph · factor Ba, factor Bb, C2, C2a, C3a, C5, C5a, C5b,...

Documents

Transcript of 1 INVENTIONS - onlineservices.ipophil.gov.ph · factor Ba, factor Bb, C2, C2a, C3a, C5, C5a, C5b,...